ELAN Stock Elanco Animal Health (ELAN, $21.73) was a top weekly gainer, with a +9.42% jump
at Tickeron.com
Loading...
Elanco Animal Health (ELAN, $21.73) was one of the top gainers this week, climbing to $21.73 per share. A.I.dvisor analyzed 209 stocks in the Pharmaceuticals: Generic Industry over the last week and discovered that of them (6) trended up while of them (3) trended down.
ELAN in +5.08% Uptrend, rising for three consecutive days on May 28, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ELAN advanced for three days, in of 261 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on May 26, 2026. You may want to consider a long position or call options on ELAN as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ELAN just turned positive on May 26, 2026. Looking at past instances where ELAN's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
ELAN moved above its 50-day moving average on May 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Bearish Trend Analysis
The 10-day RSI Indicator for ELAN moved out of overbought territory on May 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELAN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ELAN broke above its upper Bollinger Band on May 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ELAN entered a downward trend on May 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ELAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.816) is normal, around the industry mean (145.546). P/E Ratio (374.143) is within average values for comparable stocks, (94.721). ELAN's Projected Growth (PEG Ratio) (4.042) is slightly higher than the industry average of (1.701). ELAN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.034). P/S Ratio (2.406) is also within normal values, averaging (117.816).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.